Literature DB >> 29479646

Prior fragility fracture and risk of incident ischaemic cardiovascular events: results from UK Biobank.

J Paccou1,2, S D'Angelo1, A Rhodes3, E M Curtis1, Z Raisi-Estabragh4, M Edwards1,5, K Walker-Bone1, C Cooper6,7,8, S E Petersen4, N C Harvey1,9.   

Abstract

In the large UK Biobank population-based cohort, we found that amongst men, but not women, prior fragility fracture was associated with increased risk of admission with ischaemic heart disease.
INTRODUCTION: We aimed to investigate the relationship between prior fracture and risk of incident ischaemic cardiovascular events in a UK population-based cohort.
METHODS: UK Biobank is a large prospective cohort comprising 502,637 men and women aged 40-69 years, with detailed baseline assessment. History of fracture was self-reported, and details of hospital admissions for ischaemic heart disease (IHD) (ICD-10:I20-I25) were obtained through linkage to UK Hospital Episode Statistics. Cox proportional hazards models were used to investigate the prospective relationships between prior fracture and hospital admission for men and women, controlling for age, BMI, smoking, alcohol, educational level, physical activity, systolic blood pressure, calcium and vitamin D use, ankle spacing-width, heel BUA and HRT use (women).
RESULTS: Amongst men, a fragility fracture (hip, spine, wrist or arm fracture resulting from a simple fall) within the previous 5 years was associated with a 35% increased risk of IHD admission (fully adjusted HR 1.35; 95%CI 1.00, 1.82; p = 0.047), with the relationship predominantly driven by wrist fractures. Associations with hospitalisation for angina in men were similar in age-adjusted models [HR1.54; 95%CI: 1.03, 2.30), p = 0.037], but did not remain statistical significant after full adjustment [HR 1.64; 95%CI: 0.88, 3.07); p = 0.121]. HRs for admission with angina were lower in women, and neither age- nor fully adjusted relationships attained statistical significance.
CONCLUSIONS: Prior fragility fracture is an independent risk factor for incident ischaemic cardiovascular events in men. Further work may clarify whether this association is causal or represents shared risk factors, but these findings are likely to be of value in risk assessment of both osteoporosis and cardiovascular disease.

Entities:  

Keywords:  Cardiovascular; Epidemiology; Fragility fractures; Heart; Osteoporosis

Mesh:

Year:  2018        PMID: 29479646      PMCID: PMC6015763          DOI: 10.1007/s00198-018-4426-8

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  35 in total

1.  Increased risk of stroke in the year after a hip fracture: a population-based follow-up study.

Authors:  Jiunn-Horng Kang; Shiu-Dong Chung; Sudha Xirasagar; Fu-Shan Jaw; Herng-Ching Lin
Journal:  Stroke       Date:  2010-12-23       Impact factor: 7.914

Review 2.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

3.  Severity of aortic calcification is positively associated with vertebral fracture in older men--a densitometry study in the STRAMBO cohort.

Authors:  P Szulc; E J Samelson; E Sornay-Rendu; R Chapurlat; D P Kiel
Journal:  Osteoporos Int       Date:  2012-08-08       Impact factor: 4.507

4.  Association between myocardial infarction and fractures: an emerging phenomenon.

Authors:  Yariv Gerber; L Joseph Melton; Susan A Weston; Véronique L Roger
Journal:  Circulation       Date:  2011-06-27       Impact factor: 29.690

5.  Peripheral arterial disease is associated with higher rates of hip bone loss and increased fracture risk in older men.

Authors:  Tracie C Collins; Susan K Ewing; Susan J Diem; Brent C Taylor; Eric S Orwoll; Steven R Cummings; Elsa S Strotmeyer; Kristine E Ensrud
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

6.  Cardiovascular diseases and risk of hip fracture.

Authors:  Ulf Sennerby; Håkan Melhus; Rolf Gedeborg; Liisa Byberg; Hans Garmo; Anders Ahlbom; Nancy L Pedersen; Karl Michaëlsson
Journal:  JAMA       Date:  2009-10-21       Impact factor: 56.272

7.  Hip fracture and risk of acute myocardial infarction: a nationwide study.

Authors:  Chia-Hung Chiang; Chia-Jen Liu; Ping-Jen Chen; Chin-Chou Huang; Chien-Yi Hsu; Zu-Yin Chen; Wan-Leong Chan; Po-Hsun Huang; Tzeng-Ji Chen; Chia-Min Chung; Shing-Jong Lin; Jaw-Wen Chen; Hsin-Bang Leu
Journal:  J Bone Miner Res       Date:  2013-02       Impact factor: 6.741

Review 8.  Vascular calcification.

Authors:  Ziad A Massy; Tilman B Drüeke
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-07       Impact factor: 2.894

Review 9.  Immunology of Osteoporosis: A Mini-Review.

Authors:  Peter Pietschmann; Diana Mechtcheriakova; Anastasia Meshcheryakova; Ursula Föger-Samwald; Isabella Ellinger
Journal:  Gerontology       Date:  2015-06-17       Impact factor: 5.140

10.  Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links.

Authors:  A Fisher; W Srikusalanukul; M Davis; P Smith
Journal:  Clin Interv Aging       Date:  2013-02-25       Impact factor: 4.458

View more
  3 in total

1.  Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project.

Authors:  Björn Runesson; Marco Trevisan; Ken Iseri; Abdul Rashid Qureshi; Bengt Lindholm; Peter Barany; Carl Gustaf Elinder; Juan Jesus Carrero
Journal:  Nephrol Dial Transplant       Date:  2020-11-01       Impact factor: 5.992

Review 2.  Cardiovascular Drugs and Osteoarthritis: Effects of Targeting Ion Channels.

Authors:  Raminta Vaiciuleviciute; Daiva Bironaite; Ilona Uzieliene; Ali Mobasheri; Eiva Bernotiene
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

3.  Evaluation of the increased risk of spine fracture in patients with mood disorder compared with matched controls: a longitudinal follow-up study using a national sample cohort in Korea.

Authors:  So Young Kim; Chanyang Min; Bumjung Park; Miyoung Kim; Hyo Geun Choi
Journal:  BMJ Open       Date:  2019-11-28       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.